Status: Recruiting
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC Flow Modulation Device in the treatment of wide-necked intracranial aneurysms.
Participants needed: 214
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: phenox Inc.Updated: Jun 25, 2026Locations: 21
Eligibility criteria
Subject is ≥ 18 years [+6]
Previous flow diverter or stent within the parent vessel of the target aneurysm... [+19]